When restarting Mounjaro: Confirm with your surgical team that you may resume your regular medications Ensure you're tolerating adequate oral fluid and food intake for at least 24 hours Administer your next dose according to your usual injection schedule Monitor for gastrointestinal side effects, which may be more pronounced after a medication break If you've had a longer break from Mounjaro, your doctor may advise restarting at a lower dose and gradually increasing to your previous dose to minimise side effects
In 2013, Congress passed legislation meant to tighten regulations of compound drugs following a large-scale outbreak of meningitis linked to a pharmacy in Massachusetts
Phase 2 data reported nausea (~42%), vomiting (~20%), and diarrhoea (~18%) in the highest dose cohort, consistent with the GLP-1 class
The SELECT trial (N=17,604) showed a 20% reduction in major adverse cardiovascular events (MACE) among adults with overweight or obesity and established cardiovascular disease, independent of diabetes status [3]
Semaglutide bekerja melalui berbagai mekanisme yang mendukung pengendalian gula darah dan pengelolaan berat badan
What the evidence says GLP-1 receptor agonists and RA disease activity A 2025 study by Kellner and colleagues in ACR Open Rheumatology examined 173 RA patients with a BMI of 27 or higher who were prescribed a GLP-1 receptor agonist (semaglutide or tirzepatide), compared with 42 controls